Project ECHO NL: Opioid Use Disorder

What is Project ECHO NL?

Project ECHO NL: Opioid Use Disorder, is a virtual community advancing care and treatment for opioid use disorder in Newfoundland and Labrador. The goal is to help primary care providers and their teams build capacity in the treatment and management of opioid use disorder.

ECHO Learning Sessions

This project offers free, virtual learning sessions using an interactive, web-based platform to link health-care providers with a core interdisciplinary team of mentors with expertise in managing substance use care.

ECHO sessions are designed around case-based learning and mentorship and support health-care providers in gaining the knowledge and skills required to provide needed services in their regions.

What is ECHO?

Project ECHO (Extension for Community Healthcare Outcomes) is a global movement changing the way clinical knowledge is delivered and disseminated.

Launched in 2003, project ECHO uses proven adult learning techniques and interactive video technology to connect community providers with specialists in regular collaborative sessions.

The ECHO Model

The ECHO model is an effective approach that engages rural and remote health-care providers, enhances competencies in a given health area, and improves uptake of evidence-based practices.

The ECHO model is based on the premise of moving knowledge, not people. There are currently 896 ECHO programs and ECHO partners in 41 countries and these metrics continue to climb. For more information on Project ECHO, please visit https://echo.unm.edu/.

Primary care providers

Who is project ECHO NL – Opioid Use Disorder for?

Project ECHO NL: Opioid Use Disorder is for primary care providers and their teams, to help them build capacity in the treatment and management of opioid use disorder.

Primary care providers and opioid use disorder

Primary care providers are well-positioned to screen and assess for addiction, connect patients to treatment, and support relapse prevention. However, many clinicians do not have experience caring for individuals with opioid use disorder, may have practical questions about how to initiate and titrate treatments, and may be unaware of local clinical supports and resources.

Benefits

  • Project ECHO NL: Opioid Use Disorder will allow participants providers to acquire new skills and competencies.
  • Health-care providers will become part of a community of learners, increasing professional satisfaction and decreasing feelings of professional isolation.

Contact Us

The Provincial Opioid Dependence Treatment Centre of Excellence is coordinating Project ECHO NL: Opioid Use Disorder.

Please direct questions to Kate Lambert at Kate.Lambert@easternhealth.ca

Upcoming Sessions

A 10-session pilot cycle will begin in December 2020.

Session 1: Introduction to Opioid Agonist Treatment (OAT) Options in Newfoundland and Labrador
December 1, 2020
8:30 – 9:30 a.m. NST
Session 1 Flyer (PDF)

Session 2: Caring for Patients with Opioid Use Disorder (OUD) in the Primary Care Setting
December 15, 2020
12:00 p.m. – 1:00 p.m. NST
Session 2 Flyer (PDF)

Session 3: Harm Reduction and Overdose Prevention
January 5, 2021
8:30 a.m.– 9:30 a.m. NST
Session 3 Flyer (PDF)

Session 4: Opioid Agonist Treatment (OAT) and Pharmacy
January 19, 2021
12:00 p.m. – 1:00 p.m. NST
Session 4 Flyer (PDF)

Session 5: Trauma-Informed Care and Psychosocial Supports
February 2, 2021
8:30 a.m.– 9:30 a.m. NST
Session 5 Flyer (PDF)

Session 6: Decoding Urine Drug Screens (UDS)
February 16, 2021
12:00 p.m. – 1:00 p.m. NST
Session 6 Flyer (PDF)

Session 7: Sublocade: Indications and Use
March 2, 2021
8:30 a.m.– 9:30 a.m. NST
Session 7 Flyer (PDF)

Session 8: Opioids and Benzodiazepines
March 23, 2021
12:00 p.m. – 1:00 p.m. NST
Session 8 Flyer (PDF)

Session 9: Transitioning between Pharmacotherapies
March 30, 2021
8:30 a.m.– 9:30 a.m. NST
Session 9 Flyer (PDF)

Session 10: Special Populations
April 13, 2021
12:00 p.m. – 1:00 p.m. NST
Session 10 Flyer (PDF)

Registration

Please contact Chelsea Hynes at Chelsea.Hynes@easternhealth.ca.

Frequently Asked Questions

What’s involved in an ECHO session?

Project ECHO NL: Opioid Use Disorder sessions are one hour in length. Each session begins with a brief presentation based on the weekly curriculum topic, delivered by a guest mentor or a member of the core mentoring team. The majority of the session involves the presentation and discussion of a de-identified patient case submitted by one of the participating community providers. The session concludes with a summary of case recommendations made by both participants and mentors based on their clinical knowledge and experiences.

Who is the target audience?

The primary audience for Project ECHO NL: Opioid Use Disorder is prescribers (family physicians and nurse practitioners) and pharmacists. The secondary audience is other health-care professionals providing care for individuals with opioid use disorder, including registered nurses, licensed practical nurses, social workers, and addictions counsellors. The first five sessions of the pilot cycle are introductory, while the final five sessions will address more advanced topics.

How do I register?

Registration is free but required. Registration is completed on a per-session basis. Please contact Chelsea Hynes at Chelsea.Hynes@easternhealth.ca.

How do I participate?

All sessions take place using the Zoom videoconferencing platform. Participants can either download the Zoom application on their device or participate through their Internet browser. There will also be a phone-in option.

Can I Submit a Case for Discussion?

All participants are encouraged to contribute de-identified clinical cases for discussion during ECHO sessions. This requires completing a brief case form and presenting the case during a session (five minutes maximum). To submit a case, please contact Kate Lambert at Kate.Lambert@easternhealth.ca.

Where can I find the curriculum for the pilot cycle?

  • Session 1: Introduction to Opioid Agonist Treatment (OAT) Options in Newfoundland and Labrador
  • Session 2: Caring for Patients with Opioid Use Disorder (OUD) in the Primary Care Setting
  • Session 3: Harm Reduction and Overdose Prevention
  • Session 4: Opioid Agonist Treatment and Pharmacy
  • Session 5: Trauma-Informed Care and Psychosocial Supports
  • Session 6: Decoding Urine Drug Screens (UDS)
  • Session 7: Sublocade: Indications and Use
  • Session 8: Opioids and Benzodiazepines
  • Session 9: Transitioning between Pharmacotherapies
  • Session 10: Special Populations

Sessions 1 – 5 are introductory. Sessions 6 – 10 will cover more advanced topics

When are the sessions?

ECHO sessions are one hour, held bi-weekly on a rotating schedule of Tuesdays from 8:30 a.m. to 9:30 a.m. and 12:00 p.m. to 1:00 p.m. NST.

December 1, 2020 8:30 a.m.– 9:30 a.m. NST
December 15, 2020 12:00 p.m.– 1:00 p.m. NST
January 5, 2021 8:30 a.m.– 9:30 a.m. NST
January 19, 2021 12:00 p.m.– 1:00 p.m. NST
February 2, 2021 8:30 a.m.– 9:30 a.m. NST
February 16, 2021 12:00 p.m.– 1:00 p.m. NST
March 2, 2021 8:30 a.m.– 9:30 a.m. NST
March 23, 2021 12:00 p.m.– 1:00 p.m. NST
March 30, 2021 8:30 a.m.– 9:30 a.m. NST
April 13, 2021 12:00 p.m.– 1:00 p.m. NST

Are the ECHO sessions eligible for Mainpro+ credits?

Yes, this group learning program has been certified by the College of Family Physicians of Canada and the Newfoundland and Labrador Chapter for up to 10 Mainpro+ credits.

Where can I find out more information about ECHO programs?

For more information about ECHO programs across the country, please visit ECHO Canada. This page has an interactive map showcasing the ECHO programs that currently exist in each province and will also feature national ECHOs.

*Website content adapted from the BC ECHO on Substance Use.

Share This Page: